Evaluation of a diabetes care program using the effective coverage framework

International Journal for Quality in Health Care

Volumn 24, Issue 6, 2012, Pages 619-625

  López López, Erika ^a,b,c   Gutiérrez Soria, David ^a   Idrovo, Alvaro J ^b,c  

^a Ministry of Health ^*  (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c Vilano Group   (Colombia)

Author keywords

Access to care; Managed care; Measurement of quality; Quality indicators

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONCEPTUAL FRAMEWORK; DIABETIC FOOT; DIABETIC RETINOPATHY; DISEASE CONTROL; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT EDUCATION; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SERVICES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MEXICO; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE;

EID: 84869437977     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzs056     Document Type: Article

References (37)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
2. Arredondo A, Barceló A. The economic burden of out-ofpocket medical expenditures for patients seeking diabetes care in Mexico. Diabetologia 2007;50:2408-9.
3. Arredondo A, de Icaza E. Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico. Diabetologia 2009;52:1693-5.
4. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. J Am Med Assoc 2002;288:1775-9.
5. Wagner EH, McGregor M, Grothaus LC et al. Chronic care clinics for diabetes in primary care. A system-wide randomized trial. Diabetes Care 2001;25:695-700.
6. Knight K, Badamgarav E, Henning JM et al. A systematic review of diabetes disease management programs. Am J Manag Care 2005;11(suppl 4):242-50.
7. Aron D, Pogach L. Quality indicator for diabetes mellitus in the ambulatory setting: using Delphi method to inform performance measurement development. Qual Saf Health Care 2008;17:315-7.
8. Horrobin S. The value of life and the value of life extension. Ann N Y Acad Sci 2006;1067:94-105.
9. Illich I. Medical nemesis. 1974. J Epidemiol Community Health 2003;57:919-22.
10. Shengelia B, Tandon A, Adams OB et al. Access, utilization, quality, and effective coverage: an integrated conceptual framework and measurement strategy. Soc Sci Med 2005;61:97-109.
11. Donabedian A. The Definition of Quality and Approaches to its Assessment. Ann Harbor, Michigan: Health Administration Press, 1980.
12. Rosen B, Porath A, Pawlson LG et al. Adherence to standards of care by health maintenance organizations in Israel and the USA. Int J Qual Health Care 2011;23:15-25.
13. Sequist TD, Von Glahn T, Li A et al. Measuring chronic care delivery: patient experiences and clinical performance. Int J Qual Health Care 2012;24:206-13.
14. Martínez S, Carrasquilla G, Guerrero R et al. Cobertura efectiva de las intervenciones en salud de América Latina y el Caribe: métrica para evaluar los sistemas de salud. Salud Publica Mex 2011;53:s78-84.
15. Sundaram M, Kavookjian J, Patrick JH et al. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res 2007;16:165-77.
16. Egginton JS, Ridgeway JL, Shah ND et al. Care management for Type 2 diabetes in the United States: a systematic review and meta-analysis. BMC Health Serv Res 2012;12:72.
17. Rodríguez-Saldaña J, Jonguitud-Falcón A, Clark CL et al. Staged diabetes management in Mexico: optimizing care with limited resources. Diabetes Voice 2003;48:20-2.
18. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición (ENSANUT). Cuernavaca: Instituto Nacional de Salud Pública, 2006.
19. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud (ENSA). Cuernavaca: Instituto Nacional de Salud Pública, 2000.
20. Campbell SM, Roland MO, Buetow SA. Defining quality of care. Soc Sci Med 2000;51:1611-25.
21. Ashcroft R. What is clinical effectiveness? Stud Hist Philos Biol Biomed Sci 2002;33:219-33.
22. Miettinen OS. The modern scientific physician: 5. The useful property of an intervention. CMAJ 2001;165:1059-60.
23. Miettinen OS. The modern scientific physician: 4. The useful property of a diagnostic. CMAJ 2001;165:910-1.
24. Glasgow RE. Outcomes of and for diabetes education research. Diabetes Educ 1999;25(6 Suppl):74-88.
25. Rodbard HW, Blonde L, Braithwaite SS et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68.
26. Waugh N, Scotland G, McNamee P et al. Screening for type 2 diabetes: literature review and economic modeling. Health Technol Assess 2007;11:1-125.
27. Ginsberg HN, Maccallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia. J Clin Hypertens 2009;11:520-7.
28. Saenz A, Fernandez-Esteban I, Mataix A et al. Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;20:CD002966.
29. Funnell MM, Brown TL, Childs BP et al. National standards for diabetes self-management education. Diabetes Care 2005;32:S87-94.
30. Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2009;21:CD005268.
31. Paniagua R, Ramos A, Fabian R et al. Chronic kidney disease and dialysis in Mexico. Perit Dial Int 2007;27:405-9.
32. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005.
33. Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Medical Care 1981;19:127-40.
34. Pagán JA, Puig A, Soldo BJ. Health insurance coverage and the use of preventive services by Mexican adults. Health Econ 2007;16:1359-69.
35. Arredondo A, Orozco E, Servan E. Costs of epidemiological changes in chronic diseases in Mexico. In: Hofmann BR (ed). Health Care Costs: Causes, Effects and Control. New York: Nova Science Publishers, Inc., 2009, 128-44.
36. Sosa-Rubí SG, Galárraga O, López-Ridaura R. Diabetes treatment and control: the effect of public health insurance for the poor in Mexico. Bull World Health Organ 2009;87:512-9.
37. Gakidou E, Mallinger L, Abbott-Klafter J et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ 2011;89:172-83.